These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. CD73 controls ocular adenosine levels and protects retina from light-induced phototoxicity. Losenkova K; Takeda A; Ragauskas S; Cerrada-Gimenez M; Vähätupa M; Kaja S; Paul ML; Schmies CC; Rolshoven G; Müller CE; Sandholm J; Jalkanen S; Kalesnykas G; Yegutkin GG Cell Mol Life Sci; 2022 Feb; 79(3):152. PubMed ID: 35212809 [TBL] [Abstract][Full Text] [Related]
4. Adenosine and inflammation: CD39 and CD73 are critical mediators in LPS-induced PMN trafficking into the lungs. Reutershan J; Vollmer I; Stark S; Wagner R; Ngamsri KC; Eltzschig HK FASEB J; 2009 Feb; 23(2):473-82. PubMed ID: 18838482 [TBL] [Abstract][Full Text] [Related]
5. Adenosine and the adenosine A2A receptor agonist, CGS21680, upregulate CD39 and CD73 expression through E2F-1 and CREB in regulatory T cells isolated from septic mice. Bao R; Shui X; Hou J; Li J; Deng X; Zhu X; Yang T Int J Mol Med; 2016 Sep; 38(3):969-75. PubMed ID: 27430240 [TBL] [Abstract][Full Text] [Related]
8. Extracellular generation of adenosine by the ectonucleotidases CD39 and CD73 promotes dermal fibrosis. Fernández P; Perez-Aso M; Smith G; Wilder T; Trzaska S; Chiriboga L; Franks A; Robson SC; Cronstein BN; Chan ESL Am J Pathol; 2013 Dec; 183(6):1740-1746. PubMed ID: 24266925 [TBL] [Abstract][Full Text] [Related]
9. The role of the CD39-CD73-adenosine pathway in liver disease. Wang S; Gao S; Zhou D; Qian X; Luan J; Lv X J Cell Physiol; 2021 Feb; 236(2):851-862. PubMed ID: 32648591 [TBL] [Abstract][Full Text] [Related]
10. Natural killer T cell dysfunction in CD39-null mice protects against concanavalin A-induced hepatitis. Beldi G; Wu Y; Banz Y; Nowak M; Miller L; Enjyoji K; Haschemi A; Yegutkin GG; Candinas D; Exley M; Robson SC Hepatology; 2008 Sep; 48(3):841-52. PubMed ID: 18752325 [TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical and functional analysis of ectonucleoside triphosphate diphosphohydrolase 1 (CD39) and ecto-5'-nucleotidase (CD73) in pig aortic valves. Kaniewska E; Sielicka A; Sarathchandra P; Pelikant-Małecka I; Olkowicz M; Słomińska EM; Chester AH; Yacoub MH; Smoleński RT Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):305-12. PubMed ID: 24940684 [TBL] [Abstract][Full Text] [Related]
12. CD73 regulates anti-inflammatory signaling between apoptotic cells and endotoxin-conditioned tissue macrophages. Murphy PS; Wang J; Bhagwat SP; Munger JC; Janssen WJ; Wright TW; Elliott MR Cell Death Differ; 2017 Mar; 24(3):559-570. PubMed ID: 28060378 [TBL] [Abstract][Full Text] [Related]
13. Functional analysis of expression of human ecto-nucleoside triphosphate diphosphohydrolase-1 and/or ecto-5'-nucleotidase in pig endothelial cells. De Giorgi M; Pelikant-Malecka I; Sielicka A; Slominska EM; Giovannoni R; Cinti A; Cerrito MG; Lavitrano M; Smolenski RT Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):313-8. PubMed ID: 24940685 [TBL] [Abstract][Full Text] [Related]
14. CD39 and CD73 activity are protective in a mouse model of antiphospholipid antibody-induced miscarriages. Samudra AN; Dwyer KM; Selan C; Freddi S; Murray-Segal L; Nikpour M; Hickey MJ; Peter K; Robson SC; Sashindranath M; Cowan PJ; Nandurkar HH J Autoimmun; 2018 Mar; 88():131-138. PubMed ID: 29103803 [TBL] [Abstract][Full Text] [Related]
15. A novel mechanism of B cell-mediated immune suppression through CD73 expression and adenosine production. Kaku H; Cheng KF; Al-Abed Y; Rothstein TL J Immunol; 2014 Dec; 193(12):5904-13. PubMed ID: 25392527 [TBL] [Abstract][Full Text] [Related]
16. Pharmacological blockade of the CD39/CD73 pathway but not adenosine receptors augments disease in a humanized mouse model of graft-versus-host disease. Geraghty NJ; Watson D; Sluyter R Immunol Cell Biol; 2019 Jul; 97(6):597-610. PubMed ID: 30957314 [TBL] [Abstract][Full Text] [Related]
17. Conversion of ATP to adenosine by CD39 and CD73 in multiple myeloma can be successfully targeted together with adenosine receptor A2A blockade. Yang R; Elsaadi S; Misund K; Abdollahi P; Vandsemb EN; Moen SH; Kusnierczyk A; Slupphaug G; Standal T; Waage A; Slørdahl TS; Rø TB; Rustad E; Sundan A; Hay C; Cooper Z; Schuller AG; Woessner R; Borodovsky A; Menu E; Børset M; Sponaas AM J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32409420 [TBL] [Abstract][Full Text] [Related]